The most positive development for the last fiscal year has been a sharp reduction in leverage which positions Aurobindo Pharma for capex commitments in the API, vaccine and biosimilars space

Buy Aurobindo Pharma: target of Rs 1100: Sharekhan

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 30, 2021.

Weekly Tactical Pick | Aurobindo Pharma

Valuation at a discount to peers, but significant scope for margin improvement

Buy Aurobindo Pharma; target of Rs 1100: Sharekhan

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 11, 2021.

Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1165 in its research report dated February 11, 2021.

Aurobindo Pharma: Vaccine and API plans inject add-on growth levers

In the injectables space, Aurobindo Pharma remains constructive and targets to almost double from current annual sales base of $380 million to $650-700 million in three years backed by new plants in the US and Vizag

Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate

We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers

Buy Aurobindo Pharma: target of Rs 1024: Sharekhan

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1024 in its research report dated December 17, 2020.

COVID Vaccine: The opportunities for investors - Part I

Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation

Accumulate Aurobindo Pharma; target of Rs 921: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 921 in its research report dated November 12, 2020.

Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct

ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated November 12, 2020.

Buy Aurobindo Pharma; target of Rs 980: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 980 in its research report dated November 12, 2020.

Buy Aurobindo Pharma: target of Rs 1024: Sharekhan

Sharekhan is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1024 in its research report dated November 12, 2020.

Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 985 in its research report dated October 26, 2020.

Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct

ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated October 26, 2020.

Buy Aurobindo Pharma; target of Rs 1030: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1030 in its research report dated September 27, 2020.

Buy Aurobindo Pharma; target of Rs 975: Sharekhan

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 975 in its research report dated September 22, 2020.

Aurobindo Pharma: Shot in the arm for Covid vaccine development programme

Vaccine capacity creation puts Aurobindo in the league of Serum Institute of India and Cadila in the race for a Covid drug

Buy Aurobindo Pharma; target of Rs 1027: KR Choksey

KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1027 in its research report dated August 17, 2020.

Buy Aurobindo Pharma; target of Rs 1000: Emkay Global Financial

Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated August 13, 2020.

Hold Aurobindo Pharma; target of Rs 838: Prabhudas Lilladher

Prabhudas Lilladher recommended Hold rating on Aurobindo Pharma with a target price of Rs 838 in its research report dated August 13, 2020.

Hold Aurobindo Pharma; target of Rs 975: Sharekhan

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 975 in its research report dated August 13, 2020.

Buy Aurobindo Pharma; target of Rs 1055: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1055 in its research report dated August 13, 2020.

Aurobindo Pharma: Debt reduction lends confidence

Aurobindo is building capacities for emerging drug delivery systems in the US and could be a key beneficiary of the localisation initiative there

Buy Aurobindo Pharma; target of Rs 1100: ICICI Direct

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated August 13, 2020.